abstract |
FIELD: organic chemistry, medicine. SUBSTANCE: invention relates to the use of (S)-(-)-α-ethyl-2-oxo-1-pyrrolidine acetamide of the formula: as an active component that can be used for treatment of patients with anxiety (disturbance). EFFECT: enhanced effectiveness of an agent, absence of diverse effects. 4 cl, 9 tbl |